Descriptor English: | Aripiprazole | ||||||
Descriptor Spanish: |
Aripiprazol
| ||||||
Descriptor Portuguese: | Aripiprazol | ||||||
Descriptor French: | Aripiprazole | ||||||
Entry term(s): |
7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone Abilify Aripiprazol OPC 14597 OPC-14597 |
||||||
Tree number(s): |
D03.383.606.170 D03.633.100.810.835.122 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000068180 | ||||||
Scope note: | A piperazine and quinolone derivative that is used primarily as an antipsychotic agent. It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR, 5-HT2A. It is used for the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER, and as an adjunct therapy for the treatment of depression. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antidepressive Agents Antipsychotic Agents Dopamine Agonists Serotonin 5-HT1 Receptor Agonists Serotonin 5-HT2 Receptor Antagonists Dopamine D2 Receptor Antagonists |
||||||
Registry Number: | 82VFR53I78 | ||||||
Public MeSH Note: | 2016; ARIPIPRAZOLE was indexed under QUINOLONES 1995-2015 and under PIPERAZINES 1995-2015 |
||||||
History Note: | 2016 (1995) |
||||||
DeCS ID: | 55922 | ||||||
Unique ID: | D000068180 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2016/01/01 | ||||||
Date of Entry: | 2015/07/01 | ||||||
Revision Date: | 2018/06/20 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Aripiprazole
- Preferred
Abilify
- Narrower
OPC 14597
- Narrower
Concept UI |
M000602020 |
Scope note | A piperazine and quinolone derivative that is used primarily as an antipsychotic agent. It is a partial agonist of SEROTONIN RECEPTOR, 5-HT1A and DOPAMINE D2 RECEPTORS, where it also functions as a post-synaptic antagonist, and an antagonist of SEROTONIN RECEPTOR, 5-HT2A. It is used for the treatment of SCHIZOPHRENIA and BIPOLAR DISORDER, and as an adjunct therapy for the treatment of depression. |
Preferred term | Aripiprazole |
Entry term(s) |
7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone Aripiprazol |
Concept UI |
M000602022 |
Preferred term | Abilify |
Concept UI |
M0249360 |
Preferred term | OPC 14597 |
Entry term(s) |
OPC-14597 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey